288 related articles for article (PubMed ID: 20216330)
21. Infection in systemic lupus erythematosus.
Janwityanuchit S; Totemchokchyakarn K; Krachangwongchai K; Vatanasuk M
J Med Assoc Thai; 1993 Oct; 76(10):542-8. PubMed ID: 7964223
[TBL] [Abstract][Full Text] [Related]
22. The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management.
Eilertsen GØ; Becker-Merok A; Nossent JC
J Rheumatol; 2009 Mar; 36(3):552-9. PubMed ID: 19208593
[TBL] [Abstract][Full Text] [Related]
23. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort.
Petri M; Genovese M
J Rheumatol; 1992 Oct; 19(10):1559-65. PubMed ID: 1464868
[TBL] [Abstract][Full Text] [Related]
24. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
25. Incidence and clinical-laboratory aspects of systemic lupus erythematosus in a Southern brazilian city.
Nakashima CA; Galhardo AP; Silva JF; Fiorenzano GR; Santos AB; Leite MF; Nogueira MA; Menolli PV; Menolli RA
Rev Bras Reumatol; 2011; 51(3):231-9. PubMed ID: 21625811
[TBL] [Abstract][Full Text] [Related]
26. Lymphopenia as risk factor for development of severe infections in patients with systemic lupus erythematosus: a case-control study.
Merayo-Chalico J; Gómez-Martín D; Piñeirúa-Menéndez A; Santana-De Anda K; Alcocer-Varela J
QJM; 2013 May; 106(5):451-7. PubMed ID: 23458779
[TBL] [Abstract][Full Text] [Related]
27. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
Arthritis Rheum; 2006 Oct; 55(5):799-806. PubMed ID: 17013840
[TBL] [Abstract][Full Text] [Related]
28. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study.
Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED
J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514
[TBL] [Abstract][Full Text] [Related]
29. Prolonged remission in systemic lupus erythematosus.
Urowitz MB; Feletar M; Bruce IN; Ibañez D; Gladman DD
J Rheumatol; 2005 Aug; 32(8):1467-72. PubMed ID: 16078321
[TBL] [Abstract][Full Text] [Related]
30. Diffuse alveolar hemorrhage in systemic lupus erythematosus: a retrospective study in China.
Shen M; Zeng X; Tian X; Zhang F; Zeng X; Zhang X; Xu W
Lupus; 2010 Oct; 19(11):1326-30. PubMed ID: 20647253
[TBL] [Abstract][Full Text] [Related]
31. Clinical and serologic factors associated with lupus pleuritis.
Mittoo S; Gelber AC; Hitchon CA; Silverman ED; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman DD; Urowitz MB; Zummer M; Clarke AE; Bernatsky S; Hudson M; Tucker LB; Petty RE; ; Peschken CA
J Rheumatol; 2010 Apr; 37(4):747-53. PubMed ID: 20110526
[TBL] [Abstract][Full Text] [Related]
32. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
Pusongchai T; Jungthirapanich J; Khositseth S
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
[TBL] [Abstract][Full Text] [Related]
33. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
35. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
[TBL] [Abstract][Full Text] [Related]
36. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.
Wung PK; Holbrook JT; Hoffman GS; Tibbs AK; Specks U; Min YI; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune J; Ytterberg SR; Allen NB; Stone JH;
Am J Med; 2005 Dec; 118(12):1416. PubMed ID: 16378799
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of immune suppression in patients with systemic lupus erythematosus complicated by herpes zoster virus infection].
Ouyang H; He XC; Zhou Y; Li ZX
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1577-1581. PubMed ID: 27881354
[TBL] [Abstract][Full Text] [Related]
38. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study.
Appenzeller S; Pereira DA; Costallat LT
Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227
[TBL] [Abstract][Full Text] [Related]
39. [Herpes zoster in connective tissue diseases: I. Association with systemic lupus erythematosus and its immunological abnormalities].
Yamauchi Y; Nagasawa K; Tada Y; Tsukamoto H; Yoshizawa S; Mayumi T; Niho Y; Kusaba T
Kansenshogaku Zasshi; 1991 Jul; 65(7):851-6. PubMed ID: 1655920
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
Wang M; Gladman DD; Ibañez D; Urowitz MB
Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]